| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 195.37B | 169.60B | 152.41B | 125.93B | 110.05B |
| Gross Profit | 110.22B | 148.25B | 127.70B | 111.54B | 91.00B |
| EBITDA | 80.50B | 70.51B | 61.30B | 54.25B | 46.30B |
| Net Income | 54.59B | 48.45B | 43.37B | 36.74B | 32.55B |
Balance Sheet | |||||
| Total Assets | 339.31B | 312.98B | 243.48B | 217.37B | 187.37B |
| Cash, Cash Equivalents and Short-Term Investments | 148.00B | 166.78B | 125.19B | 102.12B | 107.26B |
| Total Debt | 5.10B | 11.92B | 12.16B | 11.75B | 6.10B |
| Total Liabilities | 71.59B | 86.67B | 48.39B | 56.23B | 40.89B |
| Stockholders Equity | 267.70B | 226.30B | 195.08B | 161.13B | 146.47B |
Cash Flow | |||||
| Free Cash Flow | 17.79B | 61.77B | 32.08B | 14.69B | 44.00B |
| Operating Cash Flow | 31.38B | 67.62B | 36.92B | 21.79B | 46.95B |
| Investing Cash Flow | -55.86B | -7.27B | -5.96B | -7.68B | -7.43B |
| Financing Cash Flow | -26.07B | -18.73B | -15.97B | -22.48B | -9.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥495.28B | 11.37 | ― | 2.49% | 6.31% | 10.31% | |
71 Outperform | ¥8.24T | 19.53 | 13.46% | 1.17% | 98.56% | 52.21% | |
70 Outperform | ¥2.57T | 25.66 | 17.57% | 0.84% | 17.10% | 33.90% | |
65 Neutral | ¥1.26T | 23.11 | 26.91% | 1.17% | 15.19% | 12.65% | |
63 Neutral | ¥932.51B | 31.15 | 6.70% | 1.80% | -8.27% | 21.14% | |
61 Neutral | ¥468.04B | -84.95 | -3.66% | 2.12% | 13.66% | -113.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |